Beyond Air, Inc. (NASDAQ:XAIR) CFO Douglas Beck purchased 3,000 shares of the stock in a transaction on Thursday, December 31st. The stock was bought at an average price of $5.28 per share, for a total transaction of $15,840.00. Following the completion of the transaction, the chief financial officer now directly owns 21,460 shares of the company’s stock, valued at $113,308.80. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.
XAIR stock opened at $5.27 on Friday. The company has a quick ratio of 6.51, a current ratio of 6.51 and a debt-to-equity ratio of 0.24. Beyond Air, Inc. has a twelve month low of $3.72 and a twelve month high of $12.50. The company has a market cap of $91.40 million, a P/E ratio of -3.36 and a beta of -0.66. The business has a fifty day moving average of $5.35 and a 200-day moving average of $5.79.
Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Monday, November 16th. The company reported ($0.30) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.31) by $0.01. The firm had revenue of $0.35 million for the quarter, compared to the consensus estimate of $0.15 million. As a group, equities research analysts anticipate that Beyond Air, Inc. will post -1.28 earnings per share for the current fiscal year.
Several equities research analysts have recently commented on XAIR shares. Oppenheimer restated a “buy” rating and issued a $9.00 target price on shares of Beyond Air in a research note on Tuesday, September 22nd. Zacks Investment Research raised shares of Beyond Air from a “sell” rating to a “hold” rating in a report on Saturday, October 10th.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp grew its holdings in Beyond Air by 183.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 34,809 shares of the company’s stock worth $253,000 after acquiring an additional 22,537 shares during the period. Charles Schwab Investment Management Inc. acquired a new stake in shares of Beyond Air during the second quarter worth $264,000. Bank of America Corp DE increased its holdings in Beyond Air by 59.3% in the second quarter. Bank of America Corp DE now owns 14,102 shares of the company’s stock valued at $102,000 after purchasing an additional 5,251 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in Beyond Air in the second quarter valued at about $36,000. Finally, Jane Street Group LLC boosted its holdings in Beyond Air by 37.0% during the second quarter. Jane Street Group LLC now owns 21,514 shares of the company’s stock worth $156,000 after buying an additional 5,814 shares during the last quarter. Institutional investors and hedge funds own 21.40% of the company’s stock.
About Beyond Air
Beyond Air, Inc, a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc and changed its name to Beyond Air, Inc in June 2019.
Featured Article: Is a Roth IRA right for you?
Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.